Residual tumor cells after insufficient radiofrequency ablation promote lung metastasis by educating CD177hiPAD4hi neutrophils

Nat Commun. 2025 Dec 2;17(1):208. doi: 10.1038/s41467-025-66897-0.

Abstract

Radiofrequency ablation (RFA) has been one of the most promising local treatments for colorectal liver metastases. However, tumor progression after RFA still severely affects patient prognosis, and its molecular mechanisms remain to be further explored. Here, we show that heat-stressed residual tumor cells following insufficient RFA (iRFA) can lead to lung metastases. Specific Cd177hiPad4hi neutrophils are found as the main pro-tumor phenotype in iRFA conditions, and neutrophil extracellular traps are produced to accelerate lung metastasis via the MEK/ERK signaling pathway. Mechanistically, PPARγ-triglyceride (TG) synthesis in residual tumor cells activates the P38 signaling pathway and CXCL5 secretion, contributing to Cd177hiPad4hi neutrophil infiltration. Furthermore, the specific CD36hi-EM (epithelial-mesenchymal) - circulating tumor cells (CTCs) with activated lipid metabolism characteristics are found to assist in early identification of residual tumor cells. This study not only provides specific targets for improving the efficacy of iRFA but also realizes its early identification and intervention.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Chemokine CXCL5 / metabolism
  • Colorectal Neoplasms* / pathology
  • Extracellular Traps / metabolism
  • Female
  • GPI-Linked Proteins / metabolism
  • Humans
  • Isoantigens
  • Liver Neoplasms / secondary
  • Lung Neoplasms* / metabolism
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / secondary
  • MAP Kinase Signaling System
  • Male
  • Mice
  • Neoplasm, Residual* / pathology
  • Neoplastic Cells, Circulating / metabolism
  • Neoplastic Cells, Circulating / pathology
  • Neutrophils* / immunology
  • Neutrophils* / metabolism
  • Radiofrequency Ablation* / adverse effects
  • Receptors, Cell Surface* / metabolism

Substances

  • GPI-Linked Proteins
  • CD177 protein, human
  • Chemokine CXCL5
  • Receptors, Cell Surface
  • Isoantigens